Whatever the size of your biopharmaceutical or medical device company, PAREXEL’s global presence – 86 locations in 51 countries on six continents – can accelerate your journey two crucial ways.
First, if launching your product in one key country or region is the plan, we have the end-to-end research, regulatory, patient, and commercialization assets you need in more countries – including emerging markets – than other CROs. This means your new product can be developed, tested, approved, and marketed more rapidly and smoothly, so you can help patients sooner.
Second, if you need those comprehensive resources to be in multiple markets worldwide all at once, PAREXEL is already there, with premium facilities, a rich database of patient populations, in-depth regulatory knowledge, and experienced local professionals to handle every detail.
Even more, PAREXEL’s research centers around the world are connected in real time and harmonized to the same protocols and SOPs, so whether you need us in one country or 100, you benefit from having one truly global team working together to propel your journey ahead faster, more efficiently, and more effectively from day one.